Skip to content

A cohort study of patients after PCI for coronary heart disease

A study of contemporary interpretation and clinical implementation of major diseases through the lens of Chinese medicine mechanism theory is imperative. An investigation into the modern interpretation and clinical application of precision treatment for coronary heart disease PCI (percutaneous coronary intervention) based on the theory of "stasis toxicity and depression mutually conjugated" is necessary

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000059
Enrollment
Unknown
Registered
2025-01-10
Start date
2025-01-14
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Stasis and Toxicity Depression-Conventional Western Medicine+Xuesaitong Group:Western Medicine+Xuesaitong
blood stasis and toxic depression-conventional western medicine group:conventional western medicine
Stasis and Toxicity Depression-Conventional Western Medicine+HJSSJW Group:Western Medicine+HJSSJW
Non-blood stasis and toxic depression-conventional western medicine group:conventional western medicine

Sponsors

Hangzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Diagnosis of coronary heart disease needs to meet the diagnostic criteria; 2) Patients with coronary artery disease <3 months after percutaneous coronary stent implantation and under conventional western medical treatment; 3)Cardiac function classification NYHA class I-II and ejection fraction =45%. 4) Middle-aged and elderly people (age 45-80 years old)

Exclusion criteria

Exclusion criteria: 1)cTNI >0.4 ug/L 2)Psychotropic drug users 3) Combined poorly controlled hypertension (=180/100mmHg) or hypotension (<90/60mmHg). 4) Combined with malignant arrhythmia with recent recurrence. 5) Combination of severe liver and kidney dysfunction other serious primary diseases that affect life expectancy tumors or severe mental illnesses 6)Those who have had a stroke within the last 6 months. 7)Pregnant planning to be pregnant or breastfeeding women. 8)Known bleeding tendency or bleeding disorder or uncontrollable coagulation disorders or active bleeding and invasive examination and treatment operations within 2 weeks or severe trauma or history of major surgery within 12 weeks 9) Participating in other clinical trials or allergic to experimental drugs and their constituents 10)History of current or past substance abuse or drug addiction 11) Those who have dementia or serious mental disorder that prevents them from understanding or expressing informed consent. 12) Persons with drug or alcohol dependence or other conditions t

Design outcomes

Primary

MeasureTime frame
Major Adverse Cardiovascular Events;Chinese Medicine Score;

Secondary

MeasureTime frame
Intra-stent restenosis;Hamilton Anxiety Inventory;Left ventricular end-diastolic volume index;lipids;Hamilton Depression Scale;Clinical outcomes (cardiac death in-stent restenosis admission for recurrent angina/acute coronary syndrome/heart failure/malignant arrhythmia stroke/TIA);Pittsburgh Sleep Quality Index Scale;

Countries

China

Contacts

Public ContactAisong Zhu

Zhejiang Chinese Medical University

liaoningzhongyi@hotmail.com19560164766

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026